Recordati Quote - REC

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

50.40

Bid

49.00

Offer

50.45

Volume

505,963

49.16 Day's Range 50.45

47.28 52 Week Range 54.80

Market Cap

10.35B

Previous Close

50.35

Open

50.05

Last Trade

50.4

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

274,891

Shares Outstanding

205,358,104

Dividend Yield

2.44%

PE Ratio

27.57

Earnings Per Share (EPS)

1.9

Revenue

2.07B

Net Profit

389.21M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.recordati.it

Headquarters

Milan, Lombardy, Ita

Founded

1926

Recordati SpA is listed in the Pharmaceutical Preparations sector of the Italian Stock Exchange with ticker REC. The last closing price for Recordati was 50.35 €. Over the last year, Recordati shares have traded in a share price range of 47.28 € to 54.80 €.

Recordati currently has 205,358,104 shares in issue. The market capitalisation of Recordati is 10.34 € billion. Recordati has a price to earnings ratio (PE ratio) of 27.57.

RECORDATI: CONTINUED DOUBLE-DIGIT GROWTH IN THE FIRST NINE MONTHS OF 2024 - REVENUE +12.0%, EBITDA(1) +11.8%, ADJUSTED NET INCOME(2) +9.5%

RECORDATI: CONTINUED DOUBLE-DIGIT GROWTH IN THE FIRST NINE MONTHS OF 2024 - REVENUE +12.0%, EBITDA(1) +11.8%, ADJUSTED NET INCOME(2) +9.5% Consolidated net revenue of € 1,743.1 million in the...

RECORDATI ANNOUNCES AGREEMENT TO ACQUIRE THE GLOBAL RIGHTS TO ENJAYMO®, STRENGTHENING ITS RARE DISEASES FRANCHISE

RECORDATI ANNOUNCES AGREEMENT TO ACQUIRE THE GLOBAL RIGHTS TO ENJAYMO®, STRENGTHENING ITS RARE DISEASES FRANCHISE Milan, 4th October 2024 – Recordati today announces an agreement with Sanofi...

Recordati Rare Diseases annonce la publication dans The Journal of Clinical Endocrinology & Metabolism des résultats de l’étude de Phase III LINC 4 confirmant l'efficacité et la tolérance d’Isturisa® (osilodrostat)...

L’étude LINC 4 a démontré la supériorité d’Isturisa® (osilodrostat) comparé au placebo pour normaliser le cortisol au cours de la phase de 12 semaines en double aveugle, randomisée de l’étude (77...

RECORDATI: I RISULTATI POSITIVI DELLO STUDIO DI FASE III LINC-4 PRESENTATI AL CONGRESSO ANNUALE DELLA ENDOCRINE SOCIETY RICON...

RECORDATI: I RISULTATI POSITIVI DELLO STUDIO DI FASE III LINC-4 PRESENTATI AL CONGRESSO ANNUALE DELLA ENDOCRINE SOCIETY RICONFERMANO L’EFFICACIA E LA SICUREZZA DI ISTURISA® (OSILODROSTAT) PER...

Recordati Rare Diseases: Positive Results From the Phase III LINC 4 Study Presented Today at the Endocrine Society’s Annual...

Statistically significant results from the pivotal Phase III LINC 4 study demonstrate that Isturisa® (osilodrostat) provides rapid and sustained normalisation of mean urinary free cortisol levels...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.75	-1.46627565982	51.15	51.2	49.16	256575	50.56464525	DE
4	-0.45	-0.884955752212	50.85	54.1	49.16	277341	51.37129483	DE
12	-0.3	-0.591715976331	50.7	54.8	48.58	274891	51.86174806	DE
26	2.5	5.21920668058	47.9	54.8	47.58	247369	51.15001782	DE
52	2.39	4.97812955634	48.01	54.8	47.28	235546	50.71798139	DE
156	-4.32	-7.89473684211	54.72	56.96	34.52	234687	45.66516516	DE
260	12.14	31.730266597	38.26	57.9	28.26	281582	44.95418993	DE

REC - Frequently Asked Questions (FAQ)

What is the current Recordati share price?

The current share price of Recordati is 50.40 €

How many Recordati shares are in issue?

Recordati has 205,358,104 shares in issue

What is the market cap of Recordati?

The market capitalisation of Recordati is EUR 10.34B

What is the 1 year trading range for Recordati share price?

Recordati has traded in the range of 47.28 € to 54.80 € during the past year

What is the PE ratio of Recordati?

The price to earnings ratio of Recordati is 27.57

What is the cash to sales ratio of Recordati?

The cash to sales ratio of Recordati is 5.19

What is the reporting currency for Recordati?

Recordati reports financial results in EUR

What is the latest annual turnover for Recordati?

The latest annual turnover of Recordati is EUR 2.07B

What is the latest annual profit for Recordati?

The latest annual profit of Recordati is EUR 389.21M

What is the registered address of Recordati?

The registered address for Recordati is VIA MATTEO CIVITALI 1, MILAN, LOMBARDY, 20148

What is the Recordati website address?

The website address for Recordati is www.recordati.it

Which industry sector does Recordati operate in?

Recordati operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WFTC26Finanzatech Spa	0.025 € (26.26%)	40
WART28DeodatoGallery SpA	0.0558 € (24.00%)	27.4k
WFAE25Fae Technology	0.50 € (16.23%)	20
WSGC28SG Company SpA	0.0294 € (13.51%)	1,000
WPOZ27Pozzi Milano Spa	0.102 € (13.33%)	14.05k
WPSQ26Pasquarelli Auto SpA	0.0109 € (-44.10%)	923
1CDECoeur Mining Inc	5.51 € (-20.63%)	500
1WCHWacker Chemie AG	67.50 € (-18.28%)	218
WTFINTrevi Finanziaria Industriale Spa	1.011 € (-17.54%)	2.42k
EPHEPH SpA	0.1002 € (-16.50%)	6.72k
TITTelecom Italia SpA	0.243 € (-3.19%)	370.41M
ISPIntesa Sanpaolo Spa	3.841 € (-0.31%)	137.21M
SPMSaipem Spa	2.484 € (-6.02%)	64.72M
TITRTelecom Italia	0.2813 € (-3.10%)	47.53M
ENELEnel Spa	6.804 € (0.04%)	42.28M